- Home
- BCRX vs DOLE Comparison
BCRX vs DOLE Comparison
Compare BCRX & DOLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCRX
- DOLE
- Stock Information
- Founded
- BCRX 1986
- DOLE 1851
- Country
- BCRX United States
- DOLE Ireland
- Employees
- BCRX N/A
- DOLE N/A
- Industry
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- DOLE Farming/Seeds/Milling
- Sector
- BCRX Health Care
- DOLE Consumer Staples
- Exchange
- BCRX Nasdaq
- DOLE Nasdaq
- Market Cap
- BCRX 1.6B
- DOLE 1.5B
- IPO Year
- BCRX 1994
- DOLE 2021
- Fundamental
- Price
- BCRX $7.95
- DOLE $16.57
- Analyst Decision
- BCRX Buy
- DOLE Buy
- Analyst Count
- BCRX 6
- DOLE 4
- Target Price
- BCRX $14.17
- DOLE $16.75
- AVG Volume (30 Days)
- BCRX 1.7M
- DOLE 876.4K
- Earning Date
- BCRX 10-31-2024
- DOLE 08-14-2024
- Dividend Yield
- BCRX N/A
- DOLE 1.98%
- EPS Growth
- BCRX N/A
- DOLE 110.50
- EPS
- BCRX N/A
- DOLE 2.29
- Revenue
- BCRX $382,236,000.00
- DOLE $8,360,392,000.00
- Revenue This Year
- BCRX $33.34
- DOLE $2.25
- Revenue Next Year
- BCRX $17.44
- DOLE $3.71
- P/E Ratio
- BCRX N/A
- DOLE $8.20
- Revenue Growth
- BCRX 24.65
- DOLE 2.79
- 52 Week Low
- BCRX $4.03
- DOLE $10.55
- 52 Week High
- BCRX $8.88
- DOLE $16.30
- Technical
- Relative Strength Index (RSI)
- BCRX 51.57
- DOLE 68.70
- Support Level
- BCRX $7.98
- DOLE $15.29
- Resistance Level
- BCRX $8.88
- DOLE $16.30
- Average True Range (ATR)
- BCRX 0.32
- DOLE 0.25
- MACD
- BCRX -0.08
- DOLE -0.06
- Stochastic Oscillator
- BCRX 29.32
- DOLE 100.00
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
About DOLE Dole plc
Dole PLC operates in the North American and European markets for fresh fruits and vegetables. The company's segment includes Fresh Fruit; Diversified Fresh Produce - EMEA; Diversified Fresh Produce - Americas and ROW and Fresh Vegetables. It generates maximum revenue from the Diversified Fresh Produce - EMEA segment. Diversified Fresh Produce - EMEA segment includes Dole's Irish, Dutch, Spanish, Portuguese, French, Italian, U.K., Swedish, Danish, South African, Eastern European, and Brazilian businesses, the majority of which sell a variety of imported and local fresh fruits and vegetables through retail, wholesale and, in some instances, food service channels across the European marketplace.